A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies

Cancer Cell
October 1, 2011
Cited by 334Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis